Angelini Pharma Overview

  • Year Founded
  • 1919

Year Founded

  • Status
  • Private

  • Employees
  • 5,600

Employees

  • Latest Deal Type
  • PE Growth
  • (Announced)

  • Financing Rounds
  • 3

  • Investments
  • 5

Angelini Pharma General Information

Description

Provider of wound care and dialysis solutions intended to make preventing infection simpler to improve healthcare provider compliance. The company's services include surface disinfectants, dialyze, hand hygiene, infection prevention and more.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Viale Amelia Number 70
  • 00181 Rome
  • Italy
Primary Industry
Other Pharmaceuticals and Biotechnology
Corporate Office
  • Viale Amelia Number 70
  • 00181 Rome
  • Italy

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Angelini Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Angelini Pharma‘s full profile, request access.

Request a free trial

Angelini Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of wound care and dialysis solutions intended to make preventing infection simpler to improve healthcare provid
Other Pharmaceuticals and Biotechnology
Rome, Italy
5,600 As of 2026

Libertyville, IL

Aachen, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Angelini Pharma Competitors (4)

One of Angelini Pharma’s 4 competitors is Jina Pharmaceuticals, a Corporation company based in Libertyville, IL.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Jina Pharmaceuticals Corporation Libertyville, IL
Grünenthal Private Equity-Backed Aachen, Germany
Pfizer (Vienna) Corporation Vienna, Austria
Flowonix Formerly VC-backed Hackettstown, NJ
To view Angelini Pharma’s complete competitors history, request access »

Angelini Pharma Patents

Angelini Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2020354534-A1 Pediatric trazodone compositions and method of treatment thereof Active 26-Sep-2019
AU-2020354534-B2 Pediatric trazodone compositions and method of treatment thereof Active 26-Sep-2019
CA-3153639-A1 Pediatric trazodone compositions and method of treatment thereof Active 26-Sep-2019
EP-4034117-A1 Pediatric trazodone compositions and method of treatment thereof Pending 26-Sep-2019
US-12514856-B2 Pediatric trazodone compositions and method of treatment thereof Active 26-Sep-2019 A61K31/497
To view Angelini Pharma’s complete patent history, request access »

Angelini Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Angelini Pharma Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Angelini Pharma‘s full profile, request access.

Request a free trial

Angelini Pharma Investments & Acquisitions (5)

Angelini Pharma’s most recent deal was a Merger/Acquisition with Catalyst Pharmaceuticals for . The deal was made on 16-Jul-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Catalyst Pharmaceuticals 16-Jul-2026 Merger/Acquisition Drug Discovery
GRIN Therapeutics 27-May-2025 Later Stage VC Drug Discovery
Argobio Studio 02-Mar-2021 Early Stage VC Other Pharmaceuticals and Biotechnology
Arvelle Therapeutics 02-Feb-2021 Merger/Acquisition Drug Discovery
GlaxoSmithKline (Global Rights Excluding North America AND Manufacturing Site for ThermaCare) 10-Mar-2020 Corporate Asset Purchase Buildings and Property
To view Angelini Pharma’s complete investments and acquisitions history, request access »

Angelini Pharma Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Catalyst Pharmaceuticals Coral Gables, FL 2002

Angelini Pharma FAQs

  • When was Angelini Pharma founded?

    Angelini Pharma was founded in 1919.

  • Where is Angelini Pharma headquartered?

    Angelini Pharma is headquartered in Rome, Italy.

  • What is the size of Angelini Pharma?

    Angelini Pharma has 5,600 total employees.

  • What industry is Angelini Pharma in?

    Angelini Pharma’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Angelini Pharma a private or public company?

    Angelini Pharma is a Private company.

  • What is Angelini Pharma’s current revenue?

    The current revenue for Angelini Pharma is .

  • How much funding has Angelini Pharma raised over time?

    Angelini Pharma has raised $1.26B.

  • Who are Angelini Pharma’s investors?

    CDP Equity has invested in Angelini Pharma.

  • Who are Angelini Pharma’s competitors?

    Jina Pharmaceuticals, Grünenthal, Pfizer (Vienna), and Flowonix are competitors of Angelini Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process